Fusion Pharm, Inc. (FSPM)
Lifshitz & Miller announces investigation on behalf of Fusion investors. The investigation concerns whether Fusion inflated FSPM's revenues for purported sales of PharmPods.
If you are a FSPM investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at email@example.com.